+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Therapies"

From
Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 240 Pages
  • Global
From
Squamous Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Squamous Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 240 Pages
  • Global
From
IPSC derived NK cells - Pipeline Insight, 2024 - Product Thumbnail Image

IPSC derived NK cells - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
From
From
CAR-T - Pipeline Insight, 2024 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 450 Pages
  • Global
From
From
Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 200 Pages
  • Global
From
CAR-T Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

CAR-T Therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 550 Pages
  • Global
From
Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
TCR-Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

TCR-Therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 190 Pages
  • Global
From
CAR T-Cell Therapy for Non-Hodgkin's lymphoma- - Pipeline Insight, 2024 - Product Thumbnail Image

CAR T-Cell Therapy for Non-Hodgkin's lymphoma- - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Cutaneous Squamous Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Cutaneous Squamous Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 120 Pages
  • Global
From
Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
Myelodysplastic Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Anti-CD20 antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD20 antibody - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Metastatic Liver Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Liver Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Osteosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Osteosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more